Is this the end for Cassava Sciences? After a problematic development path riddled with allegations of misleading investors, the biotech’s Alzheimer’s drug flopped on all
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Plus, news about Kanglin Biotechnology, Seelos, Orbus and Sonata: Replimune’s $125M offering: The biotech announced the offering four days after it … Sign up to
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Lack of control over their work environment fostered burnout among physicians, along with an increased desire to bail out of the organization, according to a
Last week, it was reported that an infant died from a Listeria infection in an outbreak tied to ready-to-eat-meat products. Meanwhile, recalls continue after an
HOUSTON — Preoperative embolization of meningioma was associated with improved relapse-free survival (RFS) in a retrospective propensity-matched review. Surgery without embolization was associated with a
Holder is an internist. Anna Mae* faced an impossible choice: either pay her electric bill or pay for her medication. An elderly woman with chronic